PUBLISHER: Grand View Research | PRODUCT CODE: 1842192
PUBLISHER: Grand View Research | PRODUCT CODE: 1842192
The North America artificial intelligence in healthcare market size was estimated at USD 14.66 billion in 2024 and is projected to reach USD 250.81 billion by 2033, growing at a CAGR of 37.17% from 2025 to 2033. Rapid expansion of digital health infrastructure, growing adoption of telemedicine and remote care, and increasing government investments, coupled with national artificial intelligence (AI) strategies, are factors contributing to market growth.
Robust healthcare infrastructure and substantial R&D investments by key players catalyze market growth in North America. The presence of industry leaders such as IBM, GE Healthcare, Microsoft, and Siemens Healthineers AG, among others, ensures continued innovation in AI platforms, software, and solutions. For instance, in August 2025, Philips announced plans to invest over USD 150 million in U.S. manufacturing and R&D, expanding its Pennsylvania facility that produces AI-enabled ultrasound systems and its Image Guided Therapy facility in Plymouth, Minnesota.
Moreover, the rising prevalence of chronic diseases, a growing geriatric population, and increasing healthcare costs push healthcare systems to AI for scalable solutions. AI enables predictive analytics to forecast disease progression, optimize treatment plans, and reduce unnecessary hospitalizations. Value-based care models supported by AI improve care quality and cost-effectiveness, providing measurable benefits to payers, providers, and patients.
Furthermore, increasing strategic initiatives such as new product launches, partnerships, collaborations, and mergers and acquisitions, leading to scalable AI solutions in imaging, chronic disease management, and clinical decision support, are expected to propel the market further. These partnerships ensure continuous innovation through shared expertise, resources, and validation frameworks. For instance, in June 2025, Cohere, a Canadian AI firm, in partnership with the U.S.-based Ensemble Health Partners, launched its AI healthcare agents to automate administrative tasks like appealing insurance claim denials, improving revenue cycle management (RCM), and patient experience. In addition, the proliferation of AI startups and digital health platforms fosters ecosystem growth and diverse innovation. Thus, such a collaborative ecosystem remains a strong driver of AI deployment across diverse healthcare applications in the region.
North America Artificial Intelligence In Healthcare Market Report Segmentation
This report forecasts revenue growth at the regional and country-levels and provides an analysis of industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the North America Artificial Intelligence (AI) in healthcare market report based on component, application, technology, end-use, and country: